BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 17420660)

  • 1. New insights into structural patterns encountered in glomerulosclerosis.
    LeHir M; Kriz W
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):184-91. PubMed ID: 17420660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal segmental glomerulosclerosis: recent advances.
    Pollak MR
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):138-42. PubMed ID: 18277145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of podocyte damage in the pathogenesis of glomerulosclerosis and tubulointerstitial lesions: findings in the growth hormone transgenic mouse model of progressive nephropathy].
    Wanke R; Wolf E; Brem G; Hermanns W
    Verh Dtsch Ges Pathol; 2001; 85():250-6. PubMed ID: 11894406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Permanent genetic tagging of podocytes: fate of injured podocytes in a mouse model of glomerular sclerosis.
    Asano T; Niimura F; Pastan I; Fogo AB; Ichikawa I; Matsusaka T
    J Am Soc Nephrol; 2005 Aug; 16(8):2257-62. PubMed ID: 15987751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The spectrum of focal segmental glomerulosclerosis: new insights.
    D'Agati VD
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):271-81. PubMed ID: 18408478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of disease: focal segmental glomerulosclerosis.
    Meyrier A
    Nat Clin Pract Nephrol; 2005 Nov; 1(1):44-54. PubMed ID: 16932363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic pathways are activated in each major cell type of the glomerulus in the Cd2ap mutant mouse model of focal segmental glomerulosclerosis.
    Brunskill EW; Potter SS
    BMC Nephrol; 2015 May; 16():71. PubMed ID: 25968128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models of FSGS: lessons for pathogenesis and treatment.
    Fogo AB
    Semin Nephrol; 2003 Mar; 23(2):161-71. PubMed ID: 12704576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Focal segmental glomerulosclerosis (FSGS). Molecular defects and clinical relevance].
    Schiffer M; Haller H
    Dtsch Med Wochenschr; 2006 Jul; 131(27):1541-5. PubMed ID: 16817104
    [No Abstract]   [Full Text] [Related]  

  • 10. Lessons from studies on focal segmental glomerulosclerosis: an important role for parietal epithelial cells?
    Smeets B; Dijkman HB; Wetzels JF; Steenbergen EJ
    J Pathol; 2006 Nov; 210(3):263-72. PubMed ID: 16924588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From segmental glomerulosclerosis to total nephron degeneration and interstitial fibrosis: a histopathological study in rat models and human glomerulopathies.
    Kriz W; Hosser H; Hähnel B; Gretz N; Provoost AP
    Nephrol Dial Transplant; 1998 Nov; 13(11):2781-98. PubMed ID: 9829480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 genes vpr and nef synergistically damage podocytes, leading to glomerulosclerosis.
    Zuo Y; Matsusaka T; Zhong J; Ma J; Ma LJ; Hanna Z; Jolicoeur P; Fogo AB; Ichikawa I
    J Am Soc Nephrol; 2006 Oct; 17(10):2832-43. PubMed ID: 16988066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of nonimmune glomerulosclerosis: studies in animals and potential applications to humans.
    Striker GE; He CJ; Liu ZH; Yang DC; Zalups RK; Esposito C; Striker LJ
    Lab Invest; 1995 Nov; 73(5):596-605. PubMed ID: 7474933
    [No Abstract]   [Full Text] [Related]  

  • 14. [Approach of cellular mechanisms of glomerulosclerosis in a model of accelerated aging the obese Zucker rat].
    Chevalier J; Masurier C; Lavaud S; Michel O; Bariety J
    C R Seances Soc Biol Fil; 1995; 189(6):987-1007. PubMed ID: 8763029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Podocyte biology in segmental sclerosis and progressive glomerular injury.
    Barisoni L
    Adv Chronic Kidney Dis; 2012 Mar; 19(2):76-83. PubMed ID: 22449344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility.
    Kim JM; Wu H; Green G; Winkler CA; Kopp JB; Miner JH; Unanue ER; Shaw AS
    Science; 2003 May; 300(5623):1298-300. PubMed ID: 12764198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of TGF-beta on podocyte growth and disease progression in proliferative podocytopathies.
    Lee HS; Song CY
    Kidney Blood Press Res; 2010; 33(1):24-9. PubMed ID: 20185928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRPC6 - a new podocyte gene involved in focal segmental glomerulosclerosis.
    Kriz W
    Trends Mol Med; 2005 Dec; 11(12):527-30. PubMed ID: 16290061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathological atlas of renal diseases: Minimal Change disease and focal glomerulosclerosis.
    Ferrario F; Rastaldi MP
    J Nephrol; 2005; 18(1):1-4. PubMed ID: 15772916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Podocyte injury and glomerular sclerosis].
    Matsusaka T
    Nihon Rinsho; 2004 Oct; 62(10):1805-10. PubMed ID: 15500122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.